From the Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland (MNB, EKZ, OA, SRZ, VCU, JWK); Department of Neuroscience Nursing, Johns Hopkins Hospital, Baltimore, Maryland (EKZ); MSquare Healthcare, Baltimore, Maryland (PR); Department of Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, Maryland (JWK); and Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland (JWK).

All correspondence should be addressed to: Mona N. Bahouth, MD, PhD, Johns Hopkins School of Medicine, 600 N Wolfe St, Phipps 486, Baltimore, MD 21287.

The study was supported by the Johns Hopkins Sheikh Khalifa Stroke Institute.

OA is the inventor of Neuroanimation therapy, I am Dolphin. Bandit, the Dolphin, is licensed to MSquare Healthcare Inc (a MindMaze, Inc, Company). OA is an advisor to MSquare Healthcare. I am Dolphin 2.0, in an FDA registered software interface called MindPod Dolphin, is used non-commercially for this study and other research studies. PR is a coinventor of Bandit the Dolphin and consultant to MSquare Healthcare. SRZ receives research funding from Ever Pharma (Austria), MindMaze (Switzerland), Harman/Samsung (United States), and Answer ALS (United States). JWK is coinventor of the underlying digital therapeutic concept. JWK serves as an advisor to MSquare Healthcare Inc and MindMaze Inc.

Financial disclosure statements have been obtained, and conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.